Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_assertion type Assertion NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_head.
- NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_assertion wasGeneratedBy ECO_0000203 NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_provenance.
- NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_assertion wasDerivedFrom befree-2016 NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_provenance.
- NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_assertion SIO_000772 19417023 NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_provenance.
- NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_assertion evidence source_evidence_literature NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_provenance.
- NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_assertion description "[Combined PCI-24781/bortezomib treatment resulted in strong synergistic apoptosis in all non-Hodgkin lymphoma lines (combination indices, 0.19-0.6) and was additive in Hodgkin lymphoma and primary CLL/SLL cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP736745.RABzdFcFpyfC8xPGW1bajr8ahL0Q5YmMUnGi0smDoVh5E130_provenance.